Geeta Ahuja

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study”.

Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study

JID Innovations(2024)10.1016/j.xjidi.2024.100311

N/A

0.297DataRank · unranked

6 citations

Geeta Ahuja, Laís Lopes Almeida Gomes, Joy Poroye, D Faden, Lillian Xie +4 more

Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans

BMC Infectious Diseases(2022)10.1186/s12879-022-07520-1

N/A

0DataRank · unranked

11 citations

Antonio Pizuorno, Folake Adeleye, Adeyinka O. Laiyemo, Maryam Mehdipour Dalivand, Farshad Aduli +38 more